Asymptomatic hyperuricemia: to treat or not to treat. A target trial emulation to assess major cardiorenal outcomes (HYPER-TTE-HARV) First published 21/11/2024 Last updated 21/11/2024 EU PAS number:EUPAS1000000386 Study Ongoing